Descriptions

Death receptor-5 (DR5) belongs to the tumor necrosis factor alpha (TNF-alpha) superfamily, contains three external cysteine-rich domain (CRD1-CRD3), and activates apoptotic signaling outside of cells. The negative regulatory function of a critical patch of positively charged residues (PPCR) within the CRD3 domain of DR3 is disrupted by sustained antibody binding, resulting in highly effective clustering of DR5 and apoptotic clustering to tumors.

Autoinhibitory domains (AIDs)

Target domain

328-422 (Death domain)

Relief mechanism

Ligand binding

Assay

Structural analysis, Mutagenesis experiment

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

14 structures for O14763

Entry ID Method Resolution Chain Position Source
1D0G X-ray 240 A R/S/T 54-183 PDB
1D4V X-ray 220 A A 69-184 PDB
1DU3 X-ray 220 A A/B/C/G/H/I 54-183 PDB
1ZA3 X-ray 335 A R/S 54-183 PDB
2H9G X-ray 232 A R/S 54-183 PDB
3X3F X-ray 210 A A 54-184 PDB
4I9X X-ray 210 A C/D 58-184 PDB
4N90 X-ray 330 A R/S/T 57-182 PDB
4OD2 X-ray 320 A S 73-183 PDB
6NHW NMR - A/B/C/D/E/F 208-242 PDB
6NHY NMR - A/B/C 208-242 PDB
6T3J X-ray 305 A E/J 58-184 PDB
8DPX NMR - A/B/C 77-184 PDB
AF-O14763-F1 Predicted AlphaFoldDB

561 variants for O14763

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1056740211 2 E>K No TOPMed
rs753825353 3 Q>* No ExAC
gnomAD
rs1190108568 3 Q>R No TOPMed
gnomAD
rs760265962 4 R>G No ExAC
TOPMed
gnomAD
rs1237680560 4 R>L No TOPMed
gnomAD
rs1237680560 4 R>Q No TOPMed
gnomAD
rs760265962 4 R>W No ExAC
TOPMed
gnomAD
rs1813085980 5 G>* No TOPMed
rs771771088
COSM3785931
7 N>S pancreas [Cosmic] No cosmic curated
ExAC
gnomAD
rs771771088 7 N>T No ExAC
gnomAD
COSM6180337 8 A>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1271897909 8 A>T No TOPMed
gnomAD
rs759200719 8 A>V No ExAC
TOPMed
gnomAD
rs770340909 9 P>R No ExAC
TOPMed
gnomAD
rs536473008 9 P>S No 1000Genomes
ExAC
gnomAD
rs1372104009 10 A>T No gnomAD
rs1303507474 11 A>T No gnomAD
rs1813084641 11 A>V No Ensembl
COSM3925021 13 G>E Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1055576017 14 A>T No TOPMed
rs1813084099 14 A>V No Ensembl
rs1563328813 15 R>Q No Ensembl
rs550701314 15 R>W No 1000Genomes
ExAC
gnomAD
rs1294645091 16 K>E No Ensembl
rs938431140 17 R>K No TOPMed
rs1813083565 18 H>Q No 1000Genomes
RCV000886676
rs41308114
19 G>D No ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1813083486 19 G>S No Ensembl
rs779936522 20 P>L No ExAC
TOPMed
gnomAD
rs1813083232 20 P>T No Ensembl
rs746151222 21 G>R No ExAC
TOPMed
gnomAD
TCGA novel 22 P>H Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1318520867 22 P>S No TOPMed
rs1251187799 23 R>K No gnomAD
rs1486450468 25 A>E No TOPMed
gnomAD
rs1262893819 26 R>W No TOPMed
gnomAD
rs985425967 27 G>R No gnomAD
rs977260397 28 A>G No TOPMed
gnomAD
rs757087287 28 A>T No ExAC
rs1213259674 29 R>T No TOPMed
gnomAD
rs1255546742 30 P>S No Ensembl
rs753595131 31 G>A No ExAC
TOPMed
gnomAD
rs755948401 32 P>A No ExAC
gnomAD
rs1129424
VAR_016153
32 P>L No UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs755948401 32 P>S No ExAC
gnomAD
rs1398922541 33 R>W No Ensembl
rs759105792 34 V>A No ExAC
gnomAD
rs1813080039 35 P>L No gnomAD
rs1813080039 35 P>R No gnomAD
rs1286915309 35 P>T No gnomAD
rs1813079875 37 T>A No Ensembl
rs1813079797 37 T>I No gnomAD
rs1452869399 38 L>H No gnomAD
rs1452869399 38 L>P No gnomAD
rs774194756 39 V>L No ExAC
TOPMed
gnomAD
rs774194756 39 V>M No ExAC
TOPMed
gnomAD
rs1813079385 40 L>F No TOPMed
rs1813079385 40 L>V No TOPMed
rs1436796732 41 V>I No TOPMed
gnomAD
TCGA novel 41 V>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1813079043 42 V>L No Ensembl
rs1813078888 43 A>T No TOPMed
rs1417734654 43 A>V No Ensembl
TCGA novel
rs1813078724
44 A>V Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
rs1379244176 47 L>P No Ensembl
rs769215218 47 L>V No ExAC
gnomAD
rs772531351 49 V>A No ExAC
gnomAD
rs772531351 49 V>G No ExAC
gnomAD
rs1392147672 51 A>V No gnomAD
rs774359941 52 E>D No ExAC
TOPMed
gnomAD
rs201504540 52 E>G No ExAC
TOPMed
gnomAD
rs771146779 53 S>F No ExAC
gnomAD
rs2128815918 53 S>P No Ensembl
rs377645383 54 A>T No ESP
TOPMed
gnomAD
rs749539629 56 I>V No ExAC
rs1812259636
COSM4893742
57 T>I Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
gnomAD
rs1474471373 59 Q>E No gnomAD
rs747943006 60 D>E No ExAC
TOPMed
gnomAD
rs1289639007 60 D>H No TOPMed
rs1317869813 61 L>V No TOPMed
gnomAD
rs781307433 62 A>T No ExAC
TOPMed
gnomAD
rs141261834 63 P>R No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 63 P>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1439147677 63 P>T No gnomAD
rs779636261 64 Q>H No ExAC
gnomAD
rs1563315889 65 Q>* No TOPMed
rs954345206 66 R>S No Ensembl
rs757973146 66 R>T No ExAC
TOPMed
gnomAD
rs1047266 67 A>E No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1047266 67 A>G No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs750099768 67 A>T Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
rs1047266
VAR_016154
67 A>V No UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs753058398 68 A>V No ExAC
TOPMed
gnomAD
COSM1699813
rs768030379
69 P>S skin [Cosmic] No cosmic curated
ExAC
gnomAD
rs1812257825 70 Q>* No Ensembl
rs774835669 70 Q>L No ExAC
gnomAD
rs774835669 70 Q>R No ExAC
gnomAD
rs201923391 71 Q>* No Ensembl
TCGA novel 73 R>E Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA
rs891013809 73 R>K No TOPMed
rs1404075777 74 S>A No gnomAD
rs1472793193 74 S>C No TOPMed
gnomAD
rs202151480 75 S>N No 1000Genomes
ESP
ExAC
gnomAD
rs1159473571 75 S>R No gnomAD
rs1303410809 76 P>H No TOPMed
gnomAD
rs1303410809 76 P>L No TOPMed
gnomAD
rs1303410809 76 P>R No TOPMed
gnomAD
rs770017158 77 S>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
TOPMed
gnomAD
rs1177608049 78 E>D No TOPMed
gnomAD
rs866957694 78 E>G No TOPMed
gnomAD
rs1361645001 78 E>K No gnomAD
rs1454385930 79 G>E No gnomAD
rs1047453628 80 L>M No TOPMed
gnomAD
rs1812256189 80 L>S No Ensembl
rs747916816 83 P>A No ExAC
gnomAD
rs1374556099 83 P>H No gnomAD
rs747916816 83 P>S No ExAC
gnomAD
rs1422698978 84 G>V No gnomAD
rs1486127168 85 H>D No TOPMed
gnomAD
rs1563309153 85 H>L No Ensembl
rs1486127168 85 H>Y No TOPMed
gnomAD
rs1259943458 86 H>R No gnomAD
rs1811861769 87 I>T No TOPMed
rs1441954339 88 S>L No gnomAD
rs1273774663 89 E>Q No TOPMed
gnomAD
rs1316550648 91 G>S No TOPMed
gnomAD
rs1811861210 93 D>G No Ensembl
rs1811860977 94 C>Y No gnomAD
rs1811860558 95 I>M No TOPMed
rs1811860645 95 I>N No TOPMed
gnomAD
rs146841442 95 I>V No ESP
ExAC
TOPMed
gnomAD
rs200014104 96 S>F No 1000Genomes
ExAC
gnomAD
COSM165030
rs1446810612
97 C>Y NS [Cosmic] No cosmic curated
gnomAD
rs1354556618 98 K>T No TOPMed
gnomAD
rs765424296 99 Y>H No ExAC
gnomAD
rs761782807 102 D>N No ExAC
gnomAD
rs1476101331 103 Y>C No gnomAD
rs777038492 103 Y>H No ExAC
TOPMed
gnomAD
rs867234351 104 S>I No TOPMed
rs867234351 104 S>N No TOPMed
rs764376932 105 T>I No ExAC
gnomAD
rs760575056 106 H>Q No ExAC
TOPMed
gnomAD
rs775369143 107 W>* No ExAC
rs771911409 108 N>T No ExAC
TOPMed
gnomAD
rs745888724 109 D>E No ExAC
TOPMed
gnomAD
rs2128812460 109 D>Y No Ensembl
rs1811859103 110 L>V No TOPMed
rs770524322 115 R>C No ExAC
TOPMed
gnomAD
COSM183300
rs529765232
115 R>H Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] No cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs529765232 115 R>P No TOPMed
gnomAD
rs770524322 115 R>S No ExAC
TOPMed
gnomAD
TCGA novel 116 C>Y Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs985170916 117 T>A No TOPMed
gnomAD
rs1811858498 117 T>I No gnomAD
rs985170916 117 T>P No TOPMed
gnomAD
rs1563308996 118 R>S No TOPMed
gnomAD
rs953909031 118 R>T No TOPMed
gnomAD
rs1811858215 119 C>F No TOPMed
rs748767310 120 D>E No ExAC
TOPMed
gnomAD
rs1029452037 120 D>H No TOPMed
gnomAD
rs561183014 121 S>* No Ensembl
rs1811823450 122 G>A No TOPMed
rs1444006103 122 G>S No gnomAD
rs988809982 123 E>K No Ensembl
rs1175642876 124 V>A No TOPMed
gnomAD
rs377756817 124 V>M No ESP
ExAC
TOPMed
gnomAD
rs1300556095 125 E>D No gnomAD
rs778069442 126 L>V No ExAC
gnomAD
rs756252627 127 S>T No ExAC
gnomAD
rs753017207 128 P>H No ExAC
TOPMed
gnomAD
rs1811822354 129 C>F No Ensembl
rs1398386139 129 C>R No gnomAD
rs1313694355 130 T>N No gnomAD
rs1467704241 131 T>A No gnomAD
rs759407943 131 T>M No ExAC
TOPMed
gnomAD
rs1466133664 133 R>G No Ensembl
rs142417651 136 V>A No ESP
ExAC
TOPMed
gnomAD
rs766314790 136 V>L No ExAC
rs1811821094 137 C>R No gnomAD
rs925181423 138 Q>K No Ensembl
rs773129090 138 Q>P No ExAC
gnomAD
rs773129090 138 Q>R No ExAC
gnomAD
rs1309012450 139 C>R No Ensembl
rs1191871789 139 C>Y No gnomAD
rs761287157
COSM264111
140 E>K Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs979345082 141 E>K No TOPMed
rs964324040 142 G>C No Ensembl
rs1367098533 143 T>I Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
gnomAD
rs1367098533 143 T>N No gnomAD
rs1585208539 143 T>P No Ensembl
rs542213874 145 R>L No ExAC
TOPMed
gnomAD
rs542213874 145 R>Q No ExAC
TOPMed
gnomAD
rs149217492 145 R>W No ESP
ExAC
TOPMed
gnomAD
rs1304280291 146 E>D No Ensembl
rs1187662934 146 E>G No gnomAD
rs1228102338 146 E>K No gnomAD
rs572250195 147 E>D No 1000Genomes
ExAC
TOPMed
gnomAD
rs779082473 147 E>G No ExAC
TOPMed
gnomAD
rs1811819927 147 E>K No TOPMed
rs1811819927 147 E>Q No TOPMed
rs779082473 147 E>V No ExAC
TOPMed
gnomAD
rs560429397 148 D>V No 1000Genomes
ExAC
TOPMed
gnomAD
rs541556717 149 S>C No 1000Genomes
ExAC
TOPMed
gnomAD
rs541556717 149 S>F No 1000Genomes
ExAC
TOPMed
gnomAD
rs574425915 150 P>L No 1000Genomes
TOPMed
gnomAD
rs756303303 150 P>S No ExAC
gnomAD
rs145429085 152 M>I No ESP
ExAC
TOPMed
gnomAD
rs755099736 154 R>G No ExAC
TOPMed
gnomAD
rs751372067 154 R>Q No ExAC
TOPMed
gnomAD
rs755099736 154 R>W No ExAC
TOPMed
gnomAD
rs1811818925 156 C>R No TOPMed
gnomAD
rs555994311 157 R>C No 1000Genomes
ExAC
TOPMed
gnomAD
COSM1098205
rs765125215
157 R>H Variant assessed as Somatic; MODERATE impact. endometrium [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs555994311 157 R>S No 1000Genomes
ExAC
TOPMed
gnomAD
rs761414403 158 T>I No ExAC
TOPMed
gnomAD
TCGA novel 159 G>= Variant assessed as Somatic; LOW impact. [NCI-TCGA] No NCI-TCGA
rs1168890252 159 G>R No TOPMed
rs184681902 159 G>V No 1000Genomes
ExAC
TOPMed
gnomAD
rs1356037788 161 P>L No gnomAD
rs1811783137 163 G>W No gnomAD
rs1419773040 164 M>I No TOPMed
rs1417205378 164 M>V No TOPMed
TCGA novel
rs773655476
165 V>F Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
ExAC
gnomAD
rs773655476 165 V>I No ExAC
gnomAD
rs1277156080 166 K>N No gnomAD
rs748667891 168 G>S No ExAC
gnomAD
rs1563307737 169 D>V No Ensembl
rs1161479470 169 D>Y No TOPMed
rs1811782258 170 C>S No TOPMed
rs1401471669 171 T>A No gnomAD
rs768665858 171 T>I No ExAC
TOPMed
gnomAD
rs747060098 172 P>L No ExAC
gnomAD
rs376968508 173 W>R No ESP
ExAC
TOPMed
gnomAD
rs979392688 174 S>N No TOPMed
gnomAD
rs150063854 175 D>A No ESP
ExAC
TOPMed
gnomAD
rs1477633792 176 I>T No TOPMed
gnomAD
rs1416506370 176 I>V No TOPMed
gnomAD
rs139403599 177 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs147358455 178 C>Y Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1811781097 179 V>I No TOPMed
COSM5139817 181 K>N Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs2128811835 181 K>Q No Ensembl
rs1811780966 181 K>R No gnomAD
rs867695218
COSM1098201
182 E>* Variant assessed as Somatic; HIGH impact. large_intestine endometrium [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
Ensembl
NCI-TCGA
rs1563307682 183 S>L No Ensembl
rs954785003 184 G>S No Ensembl
rs1216121356 185 T>I Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
rs1216121356 185 T>K No TOPMed
gnomAD
rs1216121356 185 T>R No TOPMed
gnomAD
rs777735062 186 K>N No ExAC
TOPMed
gnomAD
rs755611098 187 H>Q No ExAC
TOPMed
gnomAD
rs1443121939 187 H>R No gnomAD
rs2128811829 187 H>Y No Ensembl
rs752209109 188 S>G No ExAC
gnomAD
rs767294708 188 S>I No ExAC
TOPMed
gnomAD
rs767294708 188 S>T No ExAC
TOPMed
gnomAD
rs759200886 189 G>R No ExAC
gnomAD
VAR_059831
rs13265018
191 V>A No UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs13265018 191 V>D No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs13265018 191 V>G No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs930707425 192 P>T No TOPMed
gnomAD
rs1563307636 193 A>D No Ensembl
rs765576431 195 E>A No ExAC
gnomAD
rs765576431 195 E>V No ExAC
gnomAD
TCGA novel 196 E>D Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs762213038 196 E>Q No ExAC
gnomAD
rs777040114 197 T>A No ExAC
gnomAD
rs61756238 197 T>M No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs777040114 197 T>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
rs200164006 198 V>L No 1000Genomes
ExAC
TOPMed
gnomAD
rs1395411868 199 T>N No TOPMed
rs1585207525 199 T>P No Ensembl
rs2128811817 200 S>T No Ensembl
rs150556549 201 S>I No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1476740097 201 S>R No gnomAD
rs2128811813 202 P>L No Ensembl
rs1811778382 202 P>S No gnomAD
rs1422622965 203 G>E No TOPMed
gnomAD
rs1585207508 204 T>A No TOPMed
rs1442912085 204 T>I No TOPMed
rs1585207508 204 T>P No TOPMed
rs375506479 205 P>T No ESP
ExAC
TOPMed
gnomAD
rs779175748 207 S>C No ExAC
TOPMed
gnomAD
rs779175748 207 S>F No ExAC
TOPMed
gnomAD
rs1370592638 208 P>S No TOPMed
gnomAD
rs917427472 209 C>F No TOPMed
rs917427472 209 C>Y No TOPMed
rs749071336 210 S>A No ExAC
gnomAD
rs777597648 210 S>F No ExAC
gnomAD
rs1232561538 213 G>S No TOPMed
gnomAD
rs756025456 214 I>V No ExAC
gnomAD
rs1257771162 215 I>N No TOPMed
gnomAD
rs1585207425 216 I>M No Ensembl
rs888381397 216 I>T No TOPMed
gnomAD
rs1308583224 216 I>V No TOPMed
COSM1098197 217 G>* Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1380815614 218 V>L No TOPMed
gnomAD
rs1282049665 219 T>A No gnomAD
rs1044244684 219 T>I No gnomAD
rs1044244684 219 T>R No gnomAD
rs1282049665 219 T>S No gnomAD
rs1376948334 220 V>I No gnomAD
rs61761317 221 A>E No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1585207398 221 A>P No Ensembl
rs61761317 221 A>V No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs564606277 222 A>G No 1000Genomes
ExAC
rs1811775750 222 A>P No TOPMed
gnomAD
rs564606277 222 A>V No 1000Genomes
ExAC
rs368188428 223 V>I No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs368188428 223 V>L No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs977777101 224 V>I No TOPMed
rs1172491049 225 L>S No TOPMed
gnomAD
rs759582606 226 I>M No ExAC
TOPMed
gnomAD
rs142057242 226 I>T No 1000Genomes
ExAC
TOPMed
gnomAD
rs774468297 227 V>M No ExAC
TOPMed
gnomAD
rs749054165 229 V>G No ExAC
gnomAD
rs771135483 229 V>L No ExAC
TOPMed
gnomAD
rs771135483 229 V>M No ExAC
TOPMed
gnomAD
rs1811774390 230 F>L No TOPMed
rs772997684 230 F>V No ExAC
gnomAD
rs1563307424 231 V>I No Ensembl
rs1357819008 232 C>G No Ensembl
rs375815613 232 C>S No ESP
ExAC
TOPMed
gnomAD
rs375815613 232 C>Y No ESP
ExAC
TOPMed
gnomAD
rs1287344263 234 S>F No TOPMed
gnomAD
rs781250474 235 L>S No ExAC
TOPMed
gnomAD
rs560759733 238 K>* No 1000Genomes
ExAC
gnomAD
rs978451470 239 K>N No Ensembl
rs1444485360 241 L>F No gnomAD
TCGA novel 242 P>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1271532189 243 Y>* No TOPMed
gnomAD
rs1563307384 243 Y>H No Ensembl
rs779594561 246 G>A No ExAC
TOPMed
gnomAD
rs947592465 246 G>S No Ensembl
rs779594561 246 G>V No ExAC
TOPMed
gnomAD
COSM1699812
rs758010626
249 S>L skin [Cosmic] No cosmic curated
ExAC
gnomAD
rs1256252034 251 G>A No gnomAD
rs1256252034 251 G>D No gnomAD
rs1427514960 251 G>S No gnomAD
rs1487526202 252 G>D No TOPMed
gnomAD
rs760730840 252 G>R No ExAC
gnomAD
rs760730840 252 G>S No ExAC
gnomAD
rs1487526202 252 G>V No TOPMed
gnomAD
rs1481986106 253 G>R No gnomAD
rs1811751598 254 D>G No Ensembl
rs775274443 254 D>H No ExAC
TOPMed
gnomAD
rs943005989 255 P>R No TOPMed
rs1216454469 255 P>T No Ensembl
rs1319763371
COSM1623863
256 E>K liver [Cosmic] No cosmic curated
TOPMed
gnomAD
rs1319763371 256 E>Q No TOPMed
gnomAD
rs141856351 257 R>C No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs185830763 257 R>H No 1000Genomes
ExAC
TOPMed
gnomAD
rs185830763 257 R>L No 1000Genomes
ExAC
TOPMed
gnomAD
rs185830763 257 R>P No 1000Genomes
ExAC
TOPMed
gnomAD
rs141856351 257 R>S No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1326013773 258 V>E No TOPMed
gnomAD
rs1811750298 260 R>K No Ensembl
rs997126972 261 S>G No Ensembl
rs138183043
COSM4878937
264 R>* Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA Cosmic
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1327423751
COSM285842
264 R>Q Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs749002358 265 P>A No ExAC
TOPMed
gnomAD
rs530146218 265 P>H No TOPMed
gnomAD
rs749002358 265 P>S No ExAC
TOPMed
gnomAD
TCGA novel 266 G>E Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1391878339 266 G>V No gnomAD
rs777384758 267 A>P No ExAC
gnomAD
rs777384758 267 A>S No ExAC
gnomAD
rs1456024759 267 A>V No gnomAD
rs1360433797 269 D>H No TOPMed
gnomAD
rs769108466 270 N>K No ExAC
TOPMed
gnomAD
rs1415993068 270 N>S No TOPMed
gnomAD
rs964538489 271 V>A No TOPMed
rs1447514411 272 L>I No TOPMed
rs1018413365 272 L>R No TOPMed
rs780629655 273 N>Y No ExAC
TOPMed
gnomAD
COSM264110 274 E>* Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA Cosmic
COSM1456138
rs141284481
275 I>M large_intestine [Cosmic] No cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs750534468 275 I>T No ExAC
gnomAD
rs748928192 276 V>M Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
TCGA novel 277 S>N Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs760543723 280 Q>* No ExAC
gnomAD
rs1811729237 281 P>T No gnomAD
rs1345927579 282 T>A No TOPMed
gnomAD
rs138851047 282 T>N No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs767495528 283 Q>R No ExAC
gnomAD
rs759539959 284 V>A No ExAC
gnomAD
rs759539959 284 V>D No ExAC
gnomAD
rs1278343694 284 V>I No gnomAD
COSM4840745 288 E>D Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
COSM5912875 288 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs762422261 289 M>I No ExAC
gnomAD
rs765925630 289 M>V No ExAC
gnomAD
rs1279781251 294 P>T No gnomAD
rs1563306357 295 A>T No Ensembl
rs1421034767 296 E>K No gnomAD
rs769279062 299 G>D No ExAC
gnomAD
rs769279062 299 G>V No ExAC
gnomAD
rs1811726973 302 M>I No TOPMed
gnomAD
rs772479699 302 M>K No ExAC
TOPMed
gnomAD
rs772479699 302 M>R No ExAC
TOPMed
gnomAD
rs772479699 302 M>T No ExAC
TOPMed
gnomAD
rs775646524 302 M>V No ExAC
TOPMed
gnomAD
rs746434302 303 L>M No ExAC
TOPMed
gnomAD
TCGA novel 304 S>A Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
COSM3647325 305 P>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs757451275 306 G>A No ExAC
TOPMed
gnomAD
rs757451275 306 G>E No ExAC
TOPMed
gnomAD
rs1268536585 306 G>R No TOPMed
gnomAD
rs199909973
COSM4399711
307 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
ExAC
NCI-TCGA
TOPMed
gnomAD
COSM1643571
rs1811726236
308 S>L stomach [Cosmic] No cosmic curated
Ensembl
rs1205065449 310 H>Q No gnomAD
rs1811726169 310 H>Y No TOPMed
rs1346252126 311 L>M No gnomAD
rs2128811447 312 L>P No Ensembl
COSM3899000 313 E>D Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1402612177 313 E>K No TOPMed
gnomAD
rs141046996 314 P>A No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs141021862 314 P>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No 1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs141021862 314 P>R No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs141046996 314 P>S No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs141046996 314 P>T No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs771417994 316 E>D No ExAC
TOPMed
gnomAD
rs1811632982 317 A>P No Ensembl
rs1182328048 318 E>G No gnomAD
TCGA novel 318 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs2128810875 319 R>G No Ensembl
rs763429391 319 R>S No ExAC
gnomAD
rs1811632628 320 S>P No TOPMed
gnomAD
rs1239186595 323 R>K No TOPMed
gnomAD
rs2128810874 324 R>M No Ensembl
TCGA novel 325 L>H Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1811632174 327 V>I No TOPMed
rs769809226 328 P>L No ExAC
gnomAD
rs1811631983 329 A>V No Ensembl
rs1228486775 330 N>K No TOPMed
gnomAD
rs780516107 331 E>* No Ensembl
rs1357885074 331 E>D No gnomAD
rs1176101613 333 D>E No Ensembl
rs1811631352 333 D>Y No gnomAD
rs748221230 334 P>T No ExAC
gnomAD
rs781294720 335 T>I No ExAC
gnomAD
rs768805737 336 E>A No ExAC
TOPMed
gnomAD
rs1811630571 336 E>D No TOPMed
gnomAD
rs1341136453 341 C>S No TOPMed
rs778737106 343 D>H No ExAC
TOPMed
gnomAD
rs778737106 343 D>N Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
TOPMed
gnomAD
rs1585204087
COSM3834442
344 D>Y Variant assessed as Somatic; MODERATE impact. breast [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
Ensembl
rs1282621629 345 F>C No TOPMed
gnomAD
rs753715279 349 V>L No ExAC
TOPMed
gnomAD
rs753715279 349 V>M No ExAC
TOPMed
gnomAD
rs1811582115 350 P>S No TOPMed
rs201068780 352 D>N No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs201068780 352 D>Y No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs752440091 353 S>F No ExAC
gnomAD
rs375688257 354 W>* No ESP
ExAC
TOPMed
gnomAD
rs1036873542 356 P>A No TOPMed
gnomAD
rs779676594 356 P>L No ExAC
gnomAD
rs1474092693 357 L>F No TOPMed
gnomAD
rs762446032 358 M>I No ExAC
gnomAD
rs765663059 358 M>L No ExAC
gnomAD
rs888236227 360 K>N No TOPMed
gnomAD
rs1160287168 361 L>F No TOPMed
gnomAD
rs1811580555 362 G>D No TOPMed
rs760712948 364 M>I No ExAC
gnomAD
rs764204641 364 M>L No ExAC
gnomAD
rs1391291745 364 M>T No TOPMed
rs764204641 364 M>V No ExAC
gnomAD
rs775720998 365 D>N No ExAC
gnomAD
rs1456040578 365 D>V No TOPMed
rs772288130 367 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
rs745655468 368 I>T No ExAC
TOPMed
gnomAD
TCGA novel 370 V>A Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs538817078 370 V>M No 1000Genomes
ExAC
TOPMed
gnomAD
rs1397828904 372 K>R No Ensembl
rs749288232 374 E>D No ExAC
gnomAD
rs1332310747 375 A>T No TOPMed
gnomAD
rs777825298 376 A>T No ExAC
TOPMed
gnomAD
rs61756237 376 A>V No ESP
ExAC
TOPMed
gnomAD
rs1486501867 377 G>A No TOPMed
gnomAD
rs1486501867 377 G>D No TOPMed
gnomAD
rs1260037708 379 R>K No TOPMed
rs144232345 379 R>S No ESP
ExAC
TOPMed
gnomAD
rs1260037708 379 R>T No TOPMed
rs754588771 381 T>I No ExAC
gnomAD
rs1201620710 382 L>S No TOPMed
gnomAD
rs1057358825 382 L>V No Ensembl
rs1308358059 383 Y>S No TOPMed
gnomAD
rs201130588 384 T>K No ESP
ExAC
TOPMed
gnomAD
rs201130588 384 T>M No ESP
ExAC
TOPMed
gnomAD
rs201130588 384 T>R No ESP
ExAC
TOPMed
gnomAD
rs1755973745 385 M>L No TOPMed
rs1413794124 385 M>T No Ensembl
rs978935198 387 I>T No Ensembl
rs1294219488 388 K>Q No TOPMed
gnomAD
rs1811577592 389 W>* No Ensembl
rs757536315 391 N>D No ExAC
gnomAD
rs923653498 392 K>I No TOPMed
rs947473456 393 T>I No TOPMed
gnomAD
rs947473456 393 T>S No TOPMed
gnomAD
rs571677132
COSM1098195
394 G>R Variant assessed as Somatic; MODERATE impact. endometrium [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
NCI-TCGA
TOPMed
gnomAD
COSM251173
rs1176091235
394 G>V liver [Cosmic] No cosmic curated
gnomAD
rs760766067 395 R>* Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No ExAC
NCI-TCGA
TOPMed
gnomAD
rs775489972 395 R>Q Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
TOPMed
gnomAD
rs767491717 396 D>N No ExAC
TOPMed
gnomAD
rs1306046214 396 D>V No TOPMed
rs759860991 397 A>V No ExAC
TOPMed
gnomAD
rs1427464117 398 S>F No TOPMed
gnomAD
rs1256185752 399 V>I No gnomAD
rs1185382500 400 H>Y No TOPMed
gnomAD
rs774416391 401 T>N No ExAC
TOPMed
gnomAD
rs1346517798 403 L>M No TOPMed
rs770800341 404 D>A No ExAC
gnomAD
rs770800341 404 D>G No ExAC
gnomAD
TCGA novel 404 D>H Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1811575516 406 L>S No TOPMed
rs1811575574 406 L>V No TOPMed
rs115227284 408 T>M No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs780817848 410 G>E No ExAC
gnomAD
rs780817848 410 G>V No ExAC
gnomAD
rs564770528 411 E>G No 1000Genomes
ExAC
TOPMed
rs1563303865 412 R>T Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA
rs1563303859 413 L>F No Ensembl
rs148653452 413 L>H No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1585203889 414 A>G No Ensembl
rs1811574455 414 A>P No TOPMed
gnomAD
rs1811574455 414 A>T No TOPMed
gnomAD
rs1466618400 415 K>* No Ensembl
rs779539123 416 Q>L No ExAC
gnomAD
rs779539123 416 Q>R No ExAC
gnomAD
rs757649273 417 K>M No ExAC
gnomAD
rs1811573928 417 K>N No Ensembl
rs1392380873 418 I>L No gnomAD
rs745771786 418 I>T No TOPMed
gnomAD
rs1811573538 420 D>E No Ensembl
rs1430447229 420 D>Y No TOPMed
rs1399059075 421 H>N No TOPMed
gnomAD
rs1811573374 421 H>P No Ensembl
rs1170593969 422 L>F No TOPMed
rs888182475 424 S>N No gnomAD
rs754153133 426 G>R No ExAC
rs778266094 427 K>N No ExAC
TOPMed
gnomAD
rs1811572759 427 K>Q No TOPMed
gnomAD
rs1811572354 428 F>L No Ensembl
rs753189616 429 M>I No ExAC
gnomAD
rs1811572227 429 M>L No gnomAD
rs756681299 429 M>T No ExAC
gnomAD
rs1179154296 430 Y>* No gnomAD
rs759504507 430 Y>C No ExAC
TOPMed
gnomAD
rs371456402 430 Y>H No ESP
ExAC
TOPMed
gnomAD
rs371456402 430 Y>N No ESP
ExAC
TOPMed
gnomAD
rs1811571422 432 E>A No TOPMed
rs1811571312 432 E>D No gnomAD
rs1368028232 432 E>Q No TOPMed
gnomAD
rs150775344 433 G>S No ESP
ExAC
TOPMed
gnomAD
rs1811571084 435 A>G No gnomAD
rs766466093 435 A>S No ExAC
TOPMed
gnomAD
rs1192621998 436 D>Y No TOPMed
gnomAD
rs1248101177 438 A>D No gnomAD
rs762859107 438 A>S No ExAC
TOPMed
rs773078621 439 M>V No ExAC
gnomAD
rs1811569703 440 S>P No Ensembl

1 associated diseases with O14763

[MIM: 275355]: Squamous cell carcinoma of the head and neck (HNSCC)

A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. Note=The disease may be caused by variants affecting the gene represented in this entry.

Without disease ID
  • A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. Note=The disease may be caused by variants affecting the gene represented in this entry.

5 regional properties for O14763

Type Name Position InterPro Accession
domain Death domain 328 - 422 IPR000488
domain TNFR/NGFR cysteine-rich region 96 - 137 IPR001368-1
domain TNFR/NGFR cysteine-rich region 138 - 178 IPR001368-2
domain Tumor necrosis factor receptor 10, N-terminal 77 - 179 IPR034024
domain Tumour necrosis factor receptor 10A/B, death domain 341 - 428 IPR034029

Functions

Description
EC Number
Subcellular Localization
  • Membrane; Single-pass type I membrane protein
PANTHER Family PTHR46330 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B
PANTHER Subfamily PTHR46330:SF1 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B
PANTHER Protein Class transmembrane signal receptor
PANTHER Pathway Category Apoptosis signaling pathway
TRAIL-R
p53 pathway
KILLER/DR5

2 GO annotations of cellular component

Name Definition
cell surface The external part of the cell wall and/or plasma membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

3 GO annotations of molecular function

Name Definition
signaling receptor activity Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
TRAIL binding Binding to TRAIL (TNF-related apoptosis inducing ligand), a member of the tumor necrosis factor ligand family that rapidly induces apoptosis in a variety of transformed cell lines.
TRAIL receptor activity Combining with the ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) and transmitting the signal from one side of the plasma membrane to the other to initiate apoptotic cell death.

12 GO annotations of biological process

Name Definition
activation of NF-kappaB-inducing kinase activity The stimulation of the activity of NF-kappaB-inducing kinase through phosphorylation at specific residues.
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
cell surface receptor signaling pathway The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
cellular response to mechanical stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
defense response to tumor cell Reactions triggered in response to the presence of a tumor cell that act to protect the cell or organism.
extrinsic apoptotic signaling pathway via death domain receptors The series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress The series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
positive regulation of canonical NF-kappaB signal transduction Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process.
response to endoplasmic reticulum stress Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
TRAIL-activated apoptotic signaling pathway An extrinsic apoptotic signaling pathway initiated by the binding of the ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) to a death receptor on the cell surface.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9UBN6 TNFRSF10D Tumor necrosis factor receptor superfamily member 10D Homo sapiens (Human) PR
O14798 TNFRSF10C Tumor necrosis factor receptor superfamily member 10C Homo sapiens (Human) PR
O00220 TNFRSF10A Tumor necrosis factor receptor superfamily member 10A Homo sapiens (Human) SS
Q9QZM4 Tnfrsf10b Tumor necrosis factor receptor superfamily member 10B Mus musculus (Mouse) SS
10 20 30 40 50 60
MEQRGQNAPA ASGARKRHGP GPREARGARP GPRVPKTLVL VVAAVLLLVS AESALITQQD
70 80 90 100 110 120
LAPQQRAAPQ QKRSSPSEGL CPPGHHISED GRDCISCKYG QDYSTHWNDL LFCLRCTRCD
130 140 150 160 170 180
SGEVELSPCT TTRNTVCQCE EGTFREEDSP EMCRKCRTGC PRGMVKVGDC TPWSDIECVH
190 200 210 220 230 240
KESGTKHSGE VPAVEETVTS SPGTPASPCS LSGIIIGVTV AAVVLIVAVF VCKSLLWKKV
250 260 270 280 290 300
LPYLKGICSG GGGDPERVDR SSQRPGAEDN VLNEIVSILQ PTQVPEQEME VQEPAEPTGV
310 320 330 340 350 360
NMLSPGESEH LLEPAEAERS QRRRLLVPAN EGDPTETLRQ CFDDFADLVP FDSWEPLMRK
370 380 390 400 410 420
LGLMDNEIKV AKAEAAGHRD TLYTMLIKWV NKTGRDASVH TLLDALETLG ERLAKQKIED
430
HLLSSGKFMY LEGNADSAMS